Genetic testing becoming more reliable in gauging AMD risk factors

BALTIMORE — Although refinements are needed, genetic testing for risk assessment in age-related macular degeneration is gaining momentum, a speaker said here.“We’ve made great leaps in the understanding of the genetic basis behind macular degeneration in less than half a decade,” Ivana K. Kim, MD, said at Macula 2013. “Over 25 genes to date have been reported to influence AMD risk. Identification of these major genetic risk factors has elucidated some potential pathways for therapeutic intervention, namely the complement pathway.”

Full Story →